Pharma & Biotech

Sarepta Therapeutics shares closed Friday's trading session down 2.9 percent at $17.39, a decline that occurred despite a positive earnings...

BioNTech SE finds its equity caught in a significant downdraft, pressured not by its fundamentals but by emerging political risks...

Investors in Xeris Biopharma Holdings, Inc. are currently weighing contradictory market signals that present a compelling investment puzzle. On one...

Investor sentiment surrounding Ocular Therapeutix is currently a study in contrasts. The biopharmaceutical company finds itself at a crossroads, buoyed...

Eli Lilly confronts significant challenges this week as a US appellate court upheld a substantial $184 million penalty against the...

A bombshell report from the Washington Post triggered a dramatic selloff in BioNTech shares this week, wiping out gains from...

Viking Therapeutics finds itself navigating turbulent waters as its stock experiences a pronounced downward trajectory. Investor confidence has been significantly...

Protagonist Therapeutics Inc. saw its shares close at $58.86 on Friday, registering a decline of 1.37%, despite a significant corporate...

A substantial institutional investor has significantly reduced its stake in Veeva Systems, the specialized life sciences software provider. Despite the...

The biotechnology sector thrives on definitive data and clear signals, yet Ideaya Biosciences currently finds itself at the center of...